Nuclear Factor Erythroid 2-Related Factor 2 Negatively Regulates Docetaxel-Induced Ferroptosis in Castration-Resistant Prostate Cancer Cells
Open Access
- 1 January 2026
- journal article
- Published by XMLink in The World Journal of Men's Health
- Vol. 44
Abstract
Ke C, et al. World J Mens Health. 2026 ;44:e30. https://doi.org/10.5534/wjmh.250299Keywords
Funding Information
- National Natural Science Foundation of China (81702989)
- Science and Technology Program of Wuhan Technology Bureau (2025020701020257)
- Central Hospital of Wuhan (26YJ27)
This publication has 25 references indexed in Scilit:
- Molecular mechanisms of ferroptosis and its role in prostate cancer therapyCritical Reviews in Oncology/Hematology, 2022
- The Diagnosis and Treatment of Prostate CancerJAMA, 2017
- Phase I Trial of Anti‐PSMA Designer CAR‐T Cells in Prostate Cancer: Possible Role for Interacting Interleukin 2‐T Cell Pharmacodynamics as a Determinant of Clinical ResponseThe Prostate, 2016
- Taxane Mechanisms of Action: Potential Implications for Treatment Sequencing in Metastatic Castration-resistant Prostate CancerEuropean Urology, 2014
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012
- Transferrin-Mediated Cellular Iron Delivery2012
- Prostate cancer outcome and tissue levels of metal ionsThe Prostate, 2011
- Castration-resistant Prostate Cancer: From New Pathophysiology to New Treatment TargetsEuropean Urology, 2009
- Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agentsBiochimica et Biophysica Acta (BBA) - General Subjects, 2009
- Nrf2 regulates an adaptive response protecting against oxidative damage following diquat-mediated formation of superoxide anionArchives of Biochemistry and Biophysics, 2006